Figure legends
Figure 1. ROC analysis of exhaled 15-HETE, TXB2, FeNO and Δ%FEV1.
Figure 2. Changes in the levels of FeNO, FEV1and eicosanoid species during exacerbation and convalescence. The levels of (A) FeNO, (B) FEV1, (C) 15-HETE and (D) TXB2 during acute exacerbation (AE) and after treatment (C, convalescence) in a total of 75 children with asthma. Each line represents each individual sample. Note: All p-values were adjusted for multiple testing by Holm methods.
Figure 3. Changes in the levels of TXB2 and 15-HETE during exacerbation and convalescence in subjects according to the top 30%, middle 40%, and bottom 30% (as determined at the exacerbation levels). FA denotes the between-subjects main effect of stratified eicosanoid levels during exacerbation; FB denotes the within-subjects main effect of phasic change; FAXB denotes the interaction of FA and FB variables.